ASTRO 2026 keynote presenters, ASTRO convenes AI Roundtable, Public comments needed
June 3, 2026
| ASTRO 2026: Get to know keynote presenters Ezekiel Emanuel, MD, PhD, and Scott Gottlieb, MD |
 |
ASTRO is thrilled to announce the Annual Meeting keynote speakers: Ezekiel Emanuel, MD, PhD, and Scott Gottlieb, MD.
|
| ASTRO convenes AI Roundtable |
 |
| Last week, ASTRO brought together leaders from industry and across the field for our inaugural AI Roundtable. The group discussed the evolving role of artificial intelligence in radiation oncology and patient care. We extend our thanks to Fuse Oncology, MedLever, Novartis, Siemens Healthineers and Merck for sponsoring this important conversation.
Hear more on ASTRO’s initiatives around AI in a recent podcast on AI, as well as the ASTROnews spring issue. |
| June 8 Webinar: Misinformation about Prostate Cancer |
| Join ASTRO President Neha Vapiwala, MD, FASTRO, and Stacy Loeb, MD, for an upcoming webinar on June 8: Common Misinformation about Prostate Cancer and What to Do. This webinar is FREE to all ASTRO members and offers CME credits. Register today on the ASTRO Academy! |
| New Rad Onc Report: AI in RO with Kurt Sysock, CEO of Radformation | |
 |
In this episode, continuing the series on AI in Radiation Oncology, Eva Katsoulakis, MD, a member of ASTRO’s AI Resource Panel, speaks with Kurt Sysock, CEO and co-founder of Radformation. They discuss how AI is transforming the clinical workflow in radiation oncology from autosegmentation and adaptive therapy to treatment planning, quality assurance and the road ahead. Listen now! |
| New On Target Podcast: Preparing patients for prostate cancer radiation treatment | |
 |
In part two of this prostate cancer series, Christian Okoye, MD, MBA, and Anesa Ahamad, MD, explain what prostate cancer patients can expect once radiation treatment begins.
|
| ASTRO comments on the PROTEUS clinical trial |
| The results of the PROTEUS trial, offering prospective data on the management of high-risk localized and locally advanced prostate cancer, were presented May 31 at the ASCO Annual Conference and published in the New England Journal of Medicine. A summary document written by GU Resource Panel Chair Amar Kishan, MD, and ASTRO President Neha Vapiwala, MD, FASTRO, is available for ASTRO members. This serves as an excellent resource for discussions with your multidisciplinary colleagues about treatment options for your patients. |
| Public comments requested by June 10: Draft Guideline on Radiation Therapy for Hodgkin Lymphoma |
| ASTRO is seeking expert member and public feedback on our first-ever clinical practice guideline dedicated to radiation therapy for Hodgkin lymphoma.
The draft covers evidence-based recommendations for classic and nodular lymphocyte predominant Hodgkin lymphoma across upfront, combined-modality settings and in relapsed or refractory disease. Review the guideline and submit comments by June 10. 📅 You can also access both drafts at www.astro.org/PublicComment. |
| Public comments requested by June 10: Draft Active Motion Management Model Policy |
ASTRO requests feedback on the draft of the Active Motion Management (AMM) Model Policy.
📅 Review the document and submit comments through the webform by Wednesday, June 10. |
| White House proposes sweeping changes to federal grantmaking |
| This week, the White House Office of Management and Budget (OMB) published a proposed rule that would implement sweeping changes to the U.S. government’s grantmaking process. Changes include implementing review by political appointees and greater flexibility around grant cancellations. The rule would apply to every federal department. See more at What’s Happening in Washington. |
| Attention early career and trainee investigators – 2026 Publication Awards nominations open! |
This June, ASTRO celebrates early career investigators leading the way in radiation oncology as a nod to National Cancer Research Month. Nominate yourself or a colleague for the 2026 Speed of Light Publication Excellence Awards or the ARRO Health Care Access Publication Award.
Learn more about eligibility and how to apply. Applications are due July 7. |
| 2026 ASTRO Radiation Oncology Resident Fellowship – Proposals due June 29 |
| ASTRO and Speed of Light – The ASTRO Foundation are pleased to announce the 2026 ASTRO Resident Fellowship program. This program provides a radiation oncology resident (PGY-3 or later) with funding for a mentored research project and a one-year, remote assignment working part-time with AstraZeneca colleagues. One-year research proposals are requested that investigate the intersection of radiation oncology and immuno-oncology in non-small cell lung cancer. This program is supported by an educational grant from AstraZeneca. Learn more and apply! |
